Advaxis
ADXS
$0.53
Share price
-3.55%
Change (1 day)
-49.48%
Change (1 year)
Categories
Market capitalization of Advaxis (ADXS)
Market cap: $22.59 Million
As of May 2024 Advaxis has a market cap of $22.59 Million. This makes Advaxis the world's 7963th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Advaxis from 2009 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $22.59 M | 600.18% |
| 2023 | $3.22 M | 48.09% |
| 2022 | $2.17 M | -90.38% |
| 2021 | $22.66 M | -40.82% |
| 2020 | $38.29 M | -11.08% |
| 2019 | $43.06 M | 225.19% |
| 2018 | $13.24 M | -88.71% |
| 2017 | $0.11 B | -59.08% |
| 2016 | $0.28 B | -15.12% |
| 2015 | $0.33 B | 78.34% |
| 2014 | $0.18 B | 225.58% |
| 2013 | $58.17 M | 391.15% |
| 2012 | $11.84 M | -69.9% |
| 2011 | $39.35 M | 60.2% |
| 2010 | $24.56 M | 57.35% |
| 2009 | $15.61 M |
End of Day market cap according to different sources
On May 7th, 2024 the market cap of Advaxis was reported to be:
$22.59 Million
$22.59 Million
N/A
$23.44 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Genocea Biosciences
GNCA | $0 M | -99.97% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | $0.28 B | 1,178.36% | 🇺🇸 USA |
 Heska Corporation
HSKA | $1.30 B | 5,695.46% | 🇺🇸 USA |